Sign in

Daria Afenteva

@afenteva.bsky.social
40 followers 50 following 13 posts

🎓 PhD student in Biomedicine 📍 University of Helsinki, Finland 🧬 Ovarian cancer researcher 🏃‍♀️ Skier and runner

PostsRepliesMedia
Reposted by Daria Afenteva
Bioinformatics Advances @bioinfoadv.bsky.social · 09/06/2026
🧬Latest research in Bioinformatics Advances: "Identification of monotonically classifying pairs of genes for ordinal disease outcomes"  Access it here: doi.org/10.1093/bioadv/vbag143 Authors include: @afenteva.bsky.social, @caroladoerr.bsky.social
111
Reposted by Daria Afenteva
scverse @scverse.bsky.social · 02/02/2026
We will have our next community meeting on Tue, Feb 3, 2026, 11AM CST/ 9AM PST ! Philipp A will be presenting on HoloViz: High-level tools to simplify visualization in Python. Details in 🧵
101
Daria Afenteva @afenteva.bsky.social · 17/12/2025
Pikku Joulu in the lab 🎄
020
Reposted by Daria Afenteva
Institute for Molecular Medicine Finland (FIMM) @fimm-uh.bsky.social · 16/12/2025
Applications for the 2026 Leena Peltonen School of Human Genetics are open!📢 The school brings together ~20 global leaders and ~20 advanced PhD students for an intensive, discussion-driven week shaping the future of genomics. 📅 July 26–30 📍 Wellcome Genome Campus, UK 📝 Apply by March 6: lpshg.com
Promotional banner for the Leena Peltonen School of Human Genomics (LPSHG) Summer School 2026. The event takes place July 26–30, 2026 at the Wellcome Genome Campus in Hinxton, UK. The banner invites PhD students nearing completion to showcase their work and learn from 20 leading experts in human genomics through discussions and debates. Application deadline is March 6, 2026, with a website link for more information. Logos of Wellcome Sanger Institute, ESHG, and FIMM appear at the bottom, over a background image of the Wellcome Genome Campus building.
022
Daria Afenteva @afenteva.bsky.social · 10/12/2025
Had a great time at the DYNAMITE 🧨 meeting in Copenhagen this week. Huge thanks to Tuula Kallunki and the whole team for hosting us so warmly! #DYNAMITE #ovariancancer #research
010
Daria Afenteva @afenteva.bsky.social · 20/11/2025
I am grateful to @syopasaatio.bsky.social for awarding ma a dissertation grant 🌸 Huge congrats also to @anna-vaharautio.bsky.social!!!
130
Daria Afenteva @afenteva.bsky.social · 19/11/2025
Such a great panel discussion from the leading minds of the innovative cancer care today at #Slush in Helsinki 🧫🔬
000
Daria Afenteva @afenteva.bsky.social · 12/11/2025
🎉 Huge congrats to Oskari on the acceptance of his final PhD paper! He built Histolytics - a Python package for spatial analysis of whole-slide images 🌠🔬 Try it: github.com/HautaniemiLa...
010
Reposted by Daria Afenteva
Stegle Lab @steglelab.bsky.social · 07/11/2025
Are you using any of our factor models, such as MOFA? 🛵 You might’ve found it challenging to tailor them to your specific use cases - not anymore! Introducing MOFA-FLEX: a flexible, modular factor analysis framework designed for customizable modeling across diverse multi-omics data scenarios. 1/n
13412
Reposted by Daria Afenteva
Saez-Rodriguez Group @saezlab.bsky.social · 17/09/2025
🥁 Check out our new preprint on OmniPath, the prior knowledge resource for #SystemsBiology, and its brand-new OmniPath Explorer web app! 🥳 📖 Preprint: www.biorxiv.org/content/10.1... 🔍 Explorer: explore.omnipathdb.org OmniPath integrates 160+ resources for multi-omics analysis & modeling. 🧶⬇️
13921
Reposted by Daria Afenteva
Cell Reports Medicine @cp-cellrepmed.bsky.social · 01/09/2025
Online now: Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer
dlvr.it
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer
Afenteva et al. combine multi-omics, single-cell, and functional analyses to show that diminished type I interferon signaling in cancer cells underlies inherent platinum resistance in ovarian high-grade serous carcinoma. Exogenous interferon-alpha sensitizes cancer cells to cisplatin, nominating interferon pathway stimulation as a precision strategy for refractory disease.
021
Daria Afenteva @afenteva.bsky.social · 31/08/2025
🎉 After almost 3y in making, my first first-author PhD paper is out in Cell Reports Medicine! 🔗 Link: www.cell.com/cell-reports... 🧵 1/3
cell.com
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer
Afenteva et al. combine multi-omics, single-cell, and functional analyses to show that diminished type I interferon signaling in cancer cells underlies inherent platinum resistance in ovarian high-gra...
120
Reposted by Daria Afenteva
Maria Brbic @mariabrbic.bsky.social · 25/08/2025
Our Systema framework for evaluating genetic perturbation response prediction methods is now out in @natbiotech.nature.com ✨ Systema helps to evaluate perturbation response prediction methods by focusing on perturbation-specific effects rather than systematic variation 🎯
1258
Daria Afenteva @afenteva.bsky.social · 05/08/2025
🎉This is the energy every PhD paper celebration should have. Just saying 🥂😁 @gik70.bsky.social
120
Reposted by Daria Afenteva
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 31/07/2025
Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis www.biorxiv.org/content/10.1101/202…
022
Reposted by Daria Afenteva
Saez-Rodriguez Group @saezlab.bsky.social · 22/07/2025
🎉 The revised version of CORNETO, our unified Python framework for knowledge-driven network inference from omics data, is published in peer reviewed form 🔗 Paper: www.nature.com/articles/s42... 📖 News & Views: www.nature.com/articles/s42... 💻 Code: corneto.org 🧵 Thread 👇
16129
Reposted by Daria Afenteva
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 25/06/2025
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy www.biorxiv.org/content/10.1101/202…
021
Reposted by Daria Afenteva
Nature Genetics @natgenet.nature.com · 23/04/2025
📢ONLINE @naturegenet.bsky.social 📰Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring. By Wenbao Yu, Kai Tan and colleagues. ⬇️ www.nature.com/articles/s41...
nature.com
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring - Nature Genetics
Analysis of pre- and post-chemotherapy samples collected from 22 patients with high-risk neuroblastoma using single-nucleus RNA and ATAC sequencing and spatial omics characterizes therapy-related chan...
053
Reposted by Daria Afenteva
Nature Genetics @natgenet.nature.com · 13/05/2025
📢ONLINE @natgenet.nature.com 📰Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. By Avishay Spitzer, Mario L. Suvà and colleagues. ⬇️ www.nature.com/articles/s41...
nature.com
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics - Nature Genetics
Comparison of paired primary and recurrent glioblastomas at the single-cell transcriptomic level describes molecular and cellular trajectories associated with tumor recurrence, highlighting extensive ...
042
Reposted by Daria Afenteva
Nature Genetics @natgenet.nature.com · 23/06/2025
📢OUT TODAY @natgenet.nature.com 📰Predicting resistance to chemotherapy using chromosomal instability signatures. By @jsneaththompson.bsky.social, @gmaci.bsky.social and colleagues. ⬇️ www.nature.com/articles/s41...
nature.com
Predicting resistance to chemotherapy using chromosomal instability signatures - Nature Genetics
Here the authors show that chromosomal instability signatures can predict resistance to anthracycline-, taxane- and platinum-based chemotherapeutics in breast, ovarian and prostate cancer and sarcoma....
063
Reposted by Daria Afenteva
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 21/06/2025
Epigenetic Subtypes of High-Grade T1 Bladder Cancer Reveal Intra-Tumor Heterogeneity and Distinct Interactions with Tumor Microenvironment. www.biorxiv.org/content/10.1101/202…
001
Reposted by Daria Afenteva
Cell Reports Medicine @cp-cellrepmed.bsky.social · 20/06/2025
Online now: Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
dlvr.it
Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Yates and Mathey-Andrews et al. dissect the cellular and spatial heterogeneity of esophageal adenocarcinoma across clinical stages. They identify five malignant cell programs with distinct transcriptomic and epigenetic profiles, linked to disease progression, prognosis, and immune response. These programs interact with the tumor microenvironment, highlighting potential therapeutic targets.
021
Daria Afenteva @afenteva.bsky.social · 18/06/2025
Early birds today the “Meet the expert” interactive session at the #EACR2025 in Lisbon, discussing KRAS modulators.
030
Daria Afenteva @afenteva.bsky.social · 17/06/2025
Glad to have presented our work on the longitudinal dynamics of transcriptome and chromatin accessibility in HGSC at the #EACR2025 in Lisbon 🇵🇹
050
Daria Afenteva @afenteva.bsky.social · 10/06/2025
Glad to share that the Ida Montinin Fund has awarded me a personal grant to support my doctoral studies at the @helsinki.fi 🤍 Learn about Ida Montini’s legacy (in Finnish): idamontininsaatio.fi Thanks to my supervisor, Sampsa Hautaniemi, and colleagues for their support! 🙌
idamontininsaatio.fi
Ida Montinin Säätiö
010
Reposted by Daria Afenteva
Cell Reports Medicine @cp-cellrepmed.bsky.social · 07/06/2025
Online now: Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype Online now:
dlvr.it
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtype
Seo et al. demonstrate that CXCL9+ macrophages interacting with CD8+ T cells improve survival outcome in patients with residual TNBC after neoadjuvant chemotherapy, while SPP1+ macrophages and basal-like features combined with HRD predict worse survival in HR+HER2− BCs, and ERBB2 structural variants predict worse survival outcomes in HER2+ BCs.
031
Reposted by Daria Afenteva
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 07/06/2025
Improving Differential Expression and Survival Analyses with Sample Specific Compartment Deconvolution. www.biorxiv.org/content/10.1101/202…
001
Reposted by Daria Afenteva
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 07/06/2025
Optimising Chemotherapy for Locally Advanced High-Grade Serous Ovarian Cancer via Delay-Differential Equations www.biorxiv.org/content/10.1101/202…
011
Reposted by Daria Afenteva
Nature Biotechnology @natbiotech.nature.com · 04/06/2025
EpiTrace infers cell mitotic age and evolution from single-cell ATAC-seq data go.nature.com/3QHBfc3 rdcu.be/em31W
go.nature.com
Tracking single-cell evolution using clock-like chromatin accessibility loci - Nature Biotechnology
EpiTrace infers cell mitotic age and evolution from single-cell ATAC-seq data.
093
Reposted by Daria Afenteva
Manu Saraswat @manusaraswat.bsky.social · 16/05/2025
🧠 Excited to share my main PhD project! We mapped the regulatory rules governing Glioblastoma plasticity using single-cell multi-omics and deep learning. This work is part of a two-paper series with @bayraktarlab.bsky.social @oliverstegle.bsky.social and @moritzmall.bsky.social, Preprint at end🧵👇
17930
Reposted by Daria Afenteva
Itai Yanai @itaiyanai.bsky.social · 02/04/2025
🔥New Night Science paper!! Discovery happens when your initial plans fall apart but it requires you to have a particular mindset: it's not extraverted, orderly, neurotic or agreeable that's the most important – discovery requires an OPENNESS to new ideas and unexpected insights.
716557
Reposted by Daria Afenteva
Nature Biotechnology @natbiotech.nature.com · 02/04/2025
CRISPRai simultaneously activates and represses two genes in single cells go.nature.com/4apFU9q rdcu.be/efe0E
go.nature.com
Bidirectional epigenetic editing reveals hierarchies in gene regulation - Nature Biotechnology
CRISPRai simultaneously activates and represses two genes in single cells.
0225
Reposted by Daria Afenteva
Ziqi Kang @kangzq.bsky.social · 30/03/2025
Thrilled to share that our work is now published in Bioinformatics! Tribus helps discover cell identities in multiplexed imaging data. doi.org/10.1093/bioi... Huge thanks to my amazing supervisor @afarkkila.bsky.social and our team @farkkilab.bsky.social — we will keep explore spatial biology 🧬✨
doi.org
Tribus: semi-automated discovery of cell identities and phenotypes from multiplexed imaging and proteomic data
AbstractMotivation. Multiplexed imaging and single-cell analysis are increasingly applied to investigate the tissue spatial ecosystems in cancer and other
042
Reposted by Daria Afenteva
Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) @ncmbm.bsky.social · 27/03/2025
📣 Today marks the official launch of the DYNAMITE project, funded by EP PerMed with Biswa Sahu hosting the event! 💡 DYNAMITE aims to uncover the molecular mechanisms explaining why ovarian cancer cells become resistant to chemotherapy. 👀 We look forward to report on the project progress!
The 9 members of the DYNAMITE project team standing on the terrace of Oslo Science Park.
001
Reposted by Daria Afenteva
Cell Reports Medicine @cp-cellrepmed.bsky.social · 22/03/2025
Online now: The IFN-high phenotype: A biomarker-driven breakthrough in colorectal cancer treatment
dlvr.it
The IFN-high phenotype: A biomarker-driven breakthrough in colorectal cancer treatment
Patient stratification is crucial for improving immunotherapy effectiveness. Acha-Sagredo et al. identified an interferon (IFN)-high immunophenotype and CD74 overexpression as predictors for immunotherapy response in colorectal cancer (CRC). This signature, involving cytotoxic T cells and antigen-presenting macrophages, was found in both mismatch repair-deficient and -proficient CRCs. CD74 overexpression could serve as a biomarker, enabling personalized CRC treatment.
001
Reposted by Daria Afenteva
Nature Biotechnology @natbiotech.nature.com · 24/03/2025
The Protein Design Archive (PDA): insights from 40 years of protein design go.nature.com/4iNRFLI
go.nature.com
The Protein Design Archive (PDA): insights from 40 years of protein design - Nature Biotechnology
Nature Biotechnology - The Protein Design Archive (PDA): insights from 40 years of protein design
093
Reposted by Daria Afenteva
Nature Cancer @natcancer.nature.com · 17/03/2025
Online now! Li et al. show through single-cell and functional data that TME remodeling promotes peritoneal metastasis of colorectal cancer through microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells. ⬇️ www.nature.com/articles/s43...
nature.com
Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer - Nature Cancer
Li et al. show through single-cell and functional data that tumor microenvironment remodeling promotes peritoneal metastasis of colorectal cancer through microbiome dysbiosis, neutrophil recruitment a...
1106
Reposted by Daria Afenteva
Nature Biotechnology @natbiotech.nature.com · 13/03/2025
Accuracy of gene regulatory network inference is increased by combining multiome single-cell and atlas-scale bulk data go.nature.com/43YySqO rdcu.be/ebBio
go.nature.com
Inferring gene regulatory networks from single-cell multiome data using atlas-scale external data - Nature Biotechnology
Accuracy of gene regulatory network inference is increased by combining multiome single-cell and atlas-scale bulk data.
0115
Reposted by Daria Afenteva
Saez-Rodriguez Group @saezlab.bsky.social · 14/03/2025
📄 Update on our preprint about Gene Regulatory Net (GRN) benchmarking 📄 We have included the original and decoupled version of SCENIC+, added a new metric and two more databases. Dictys and SCENIC+ outperformed others, but still performed poorly in causal mechanistic tasks. doi.org/10.1101/2024... 👇
Performance of multimodal GRN inference methods. SCENIC+ and Dictys outperform others.
25018
Reposted by Daria Afenteva
Cancer Cell @cp-cancercell.bsky.social · 12/03/2025
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
dlvr.it
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
Chen et al. depict the comprehensive single-cell resolved spatial atlas of SCLC. Spatial analyses identify specific multi-positive tumor cell enriched neighborhood which correlates with aggressive pattern and transition trajectory. ColonyMap algorithm…
033
Reposted by Daria Afenteva
scverse @scverse.bsky.social · 14/02/2025
🎉 Scanpy 1.11.0 is out! 🎉 just after reaching 2000 stars on GitHub! - sc.pp.sample replaces subsample with many new features - Sparse Dask support pca - session-info2 package for more reproducible notebooks See the release notes:
buff.ly
Release notes
Version 1.11: 1.11.0 2025-02-14: Release candidates: rc2 2025-01-24, rc1 2024-12-20. Features: rc1 sample() supports both upsampling and downsampling of observations and variables. subsample() is n...
14919
Reposted by Daria Afenteva
Kari Lavikka @karilavikka.fi · 26/02/2025
Jellyfish visualization tool and the Jellyfisher R package have now been published in OUP Bioinformatics! 🎉 doi.org/10.1093/bioi... #Bioinformatics #DataViz (1/7)
doi.org
Jellyfish: integrative visualization of spatio-temporal tumor evolution and clonal dynamics
AbstractSummary. Spatial and temporal intra-tumor heterogeneity drives tumor evolution and therapy resistance. Existing visualization tools often fail to c
131
Reposted by Daria Afenteva
Saez-Rodriguez Group @saezlab.bsky.social · 20/02/2025
The first version of NetworkCommons is now published in Bioinformatics. Next, we’ll focus on involving more of the network biology community. academic.oup.com/bioinformati... In parallel, we’ll continue expanding benchmarks and developing new applications. Interested in contributing? Reach out! ⬇️
academic.oup.com
NetworkCommons: bridging data, knowledge and methods to build and evaluate context-specific biological networks
AbstractSummary. We present NetworkCommons, a platform for integrating prior knowledge, omics data, and network inference methods, facilitating their usage
04420
Reposted by Daria Afenteva
Rob Patro @robp.bsky.social · 25/01/2025
We just released simpleaf v0.19.0 (github.com/COMBINE-lab/...). Make sure to pair it with piscem v0.12 for faster scATAC-seq processing. The other big feature & first explicit @scverse.bsky.social integration point is AnnData format output with the new `--anndata-out` flag!
github.com
Release v0.19.0 · COMBINE-lab/simpleaf
Install simpleaf 0.19.0 Install prebuilt binaries via shell script curl --proto '=https' --tlsv1.2 -LsSf https://github.com/COMBINE-lab/simpleaf/releases/download/v0.19.0/simpleaf-installer.sh | sh...
0114
Reposted by Daria Afenteva
WHO @who.int · 11/02/2025
Today is International Day of Women & Girls in Science. Marie Curie, the first woman to win a Nobel Prize. Her contributions have left an indelible mark on the world of science & health & continue to inspire generations of scientists & innovators. 🔬 #WomenInScience #WomenInSTEM
Nothing in life is to be feared, it is only to be understood. Marie Curie, Physicist and chemist.
5647231866
Reposted by Daria Afenteva
scverse @scverse.bsky.social · 31/01/2025
On Tuesday at 2025-02-04 18:00 CET, @jkobject will talk about scPrint, a transformer model that infers gene networks from scRNA-seq data, at our 2nd community meeting of 2025! For more information, check out the GitHub: buff.ly/40RJ3gT & pre-print buff.ly/4hwK4Av
buff.ly
GitHub - cantinilab/scPRINT: single cell foundation model for Gene network inference and more
single cell foundation model for Gene network inference and more - cantinilab/scPRINT
2208
Reposted by Daria Afenteva
Saez-Rodriguez Group @saezlab.bsky.social · 23/12/2024
We present Gene Regulatory nETwork Analsyis (GRETA), a framework to infer, compare and evaluate gene regulatory networks #GRNs. With it, we have benchmarked multimodal and unimodal GRN inference methods. Check the results here 👇 Paper: doi.org/10.1101/2024.12.20.629764 Code: github.com/saezlab/greta
GRETA graphical abstract
112746